Popular topics to explore

★All TopicsEquity ResearchFundamental ViewsHidden GemsIndex StrategiesIPOMacro ViewsMiscellaneousPersonal FinancePost-Closing CommentaryPre-Opening CommentaryPsychology of MoneySector BreakoutStock In NewsTechnical ViewsTime To ExitToday's Trading SetupTrending SectorsWatch Out For
‹ All Posts
Kundan Motwani
Kundan Motwani

12th Jun · SEBI-Registered Analyst

DR LAL PATHLABS:

CO INCORPORATES WHOLLY OWNED SUBSIDIARY IN DUBAI, INVESTS AED 1.91 CRORE IN DR LAL PATHLABS FZCO $LALPATHLAB

#WatchOutFor#StockInNews
995 likes·63 comments